Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation
Not yet recruiting · NCT07568756 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Not yet recruiting | Phase 2 | 2026-05-06 | NCT07568756 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Blue Earth Diagnostics | 26 |
| University of California, Irvine | 157 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chao Family Comprehensive Cancer Center, University of California, Irvine | Orange | United States | 24 |